Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$0.28 - $1.16 $27.6 Million - $114 Million
-98,573,807 Reduced 42.31%
134,425,866 $44.4 Million
Q1 2024

May 01, 2024

SELL
$1.06 - $1.67 $3.49 Million - $5.5 Million
-3,292,510 Reduced 1.39%
232,999,673 $270 Million
Q4 2023

Jan 26, 2024

SELL
$1.26 - $1.79 $3.17 Million - $4.5 Million
-2,516,640 Reduced 1.05%
236,292,183 $399 Million
Q3 2023

Nov 13, 2023

SELL
$1.61 - $2.54 $3.66 Million - $5.77 Million
-2,272,582 Reduced 0.94%
238,808,823 $432 Million
Q2 2023

Jul 28, 2023

SELL
$1.14 - $1.95 $2.04 Million - $3.48 Million
-1,786,855 Reduced 0.74%
241,081,405 $448 Million
Q1 2023

May 03, 2023

SELL
$1.2 - $2.19 $1.57 Million - $2.87 Million
-1,308,383 Reduced 0.54%
242,868,260 $323 Million
Q4 2022

Jan 24, 2023

BUY
$1.63 - $3.52 $65.4 Million - $141 Million
40,099,800 Added 19.65%
244,176,643 $413 Million
Q3 2022

Oct 27, 2022

SELL
$0.73 - $3.74 $913,188 - $4.68 Million
-1,250,943 Reduced 0.61%
204,076,843 $637 Million
Q2 2022

Aug 08, 2022

BUY
$2.2 - $4.2 $82.7 Million - $158 Million
37,575,106 Added 22.4%
205,327,786 $489 Million
Q1 2022

May 05, 2022

BUY
$2.83 - $8.69 $165 Million - $507 Million
58,302,509 Added 53.27%
167,752,680 $676 Million
Q4 2021

Jan 20, 2022

BUY
$8.31 - $14.92 $153 Million - $275 Million
18,447,361 Added 20.27%
109,450,171 $910 Million
Q3 2021

Oct 19, 2021

BUY
$9.15 - $13.28 $833 Million - $1.21 Billion
91,002,810 New
91,002,810 $1.05 Billion

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.